46% of U.S. Women Prioritize Health Cost Worries Over Disease

By VirentaNews Staff — May 15, 2026

Nearly half of all American women—46%, to be exact—are more anxious about paying for health care than they are about developing life-threatening conditions such as cancer, heart disease, or diabetes, according to a groundbreaking 2024 national survey conducted by the Cleveland Clinic. This striking finding highlights a seismic shift in health-related priorities, where financial instability is eclipsing biological risk as the primary source of health anxiety. The report, which surveyed over 2,000 women across diverse demographics, reveals that economic insecurity has become so pervasive that it is now influencing preventive care decisions, medication adherence, and mental well-being. With medical costs continuing to outpace inflation and insurance gaps persisting, the psychological toll of financial strain is emerging as a silent public health crisis—one that disproportionately affects women, who are more likely to manage household health logistics and face wage disparities.

Why Cost Anxiety Now Tops Health Fears

This shift in health perception marks a pivotal moment in American health care discourse. Historically, public health campaigns have focused on raising awareness of diseases like breast cancer, cardiovascular conditions, and diabetes—all leading causes of death among women. But the Cleveland Clinic report suggests that fear of financial ruin from medical expenses has overtaken these biological threats in women’s daily consciousness. The reasons are multifaceted: rising premiums, high-deductible insurance plans, and the cost of prescription drugs have made routine care feel unattainable for many. Additionally, women are more likely than men to delay or forgo care due to cost, according to data from the CDC. With inflation affecting household budgets and stagnant wage growth, especially for lower- and middle-income women, the ability to afford care has become a more immediate and tangible fear than long-term health risks.

Survey Reveals Depth of Financial Health Stress

The Cleveland Clinic’s Women’s Health Survey, now in its third year, found that 46% of respondents ranked affordability as their top health concern, surpassing cancer (41%), heart disease (38%), and mental health (32%). The survey included women from all 50 states, spanning urban, suburban, and rural areas, with representation across income levels, races, and age groups. Notably, financial concerns were highest among women aged 30 to 45—those most likely to be balancing child care, elder care, and full-time employment. Nearly 40% of respondents admitted to skipping a recommended test or treatment due to cost in the past year, while 31% reported not filling prescriptions because of price. These behaviors, the report warns, could lead to delayed diagnoses and worsened outcomes, effectively turning economic stress into a driver of poor health.

Systemic Roots of Health Care Affordability Crisis

The underlying causes of this affordability crisis are systemic and deeply entrenched. Despite the Affordable Care Act’s expansion of coverage, millions remain underinsured or uninsured, particularly in states that did not expand Medicaid. Women, who on average earn 82 cents for every dollar earned by men, are more vulnerable to financial shocks. Pregnancy, menopause, and reproductive health care—unique to women—add layers of expense not always fully covered by insurance. Furthermore, women are more likely to be caregivers, often sacrificing their own health needs to care for others. Experts point to the growing trend of high-deductible health plans and surprise billing as major contributors to cost anxiety. A 2023 study published in Health Affairs found that even insured patients face unpredictable out-of-pocket costs, which erode trust in the system and deter preventive care.

Who Is Most Affected and How

The burden of health care cost anxiety falls hardest on low-income women, racial minorities, and those in rural areas with limited provider access. Black and Hispanic women, for instance, are more likely to report skipping care due to cost, according to federal health data. Single mothers and women with chronic conditions face compounded pressures, as ongoing treatments become financially unsustainable. The implications extend beyond physical health: chronic stress over medical bills is linked to anxiety, depression, and poor sleep, creating a feedback loop that worsens overall well-being. Employers and insurers may also feel the ripple effects through reduced productivity and higher long-term costs from untreated conditions. Ultimately, when affordability becomes a barrier to care, the entire health system becomes less effective and more expensive.

Expert Perspectives

Health economists and policy experts are divided on solutions but agree on the urgency. Dr. Karen Joynt Maddox, a cardiologist and health policy researcher at Washington University, warns that ‘when people delay care because of cost, we see later-stage diagnoses and higher mortality.’ Others, like Sally Pipes of the Pacific Research Institute, argue that market-driven reforms—not more government intervention—are the path to lower prices. However, most public health leaders emphasize the need for policy changes, such as capping insulin prices, expanding subsidies, and mandating price transparency. The American Medical Association has also called for an end to surprise billing, a practice that disproportionately affects women undergoing childbirth or complex surgeries.

As health care costs continue to strain household budgets, the question is no longer just about treating disease—but about making care accessible enough that people aren’t afraid to seek it. Policymakers, providers, and insurers must confront the financial toxicity embedded in the system. Upcoming elections may bring renewed focus on health affordability, and patient advocacy groups are pushing for legislation to protect consumers. Monitoring how these concerns influence health behaviors—and whether reforms can restore trust in the system—will be critical in the years ahead.

Source: MedicalXpress